VintaBio, a biotech manufacturing technology company specializing in high-yield, high-purity viral vector production for reliable gene therapy access, will present transformative data on its ...

Late last year, the therapy developers dosed their first patient following positive preclinical data demonstrating safety and ...

Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 cell lines for advanced therapies; Complements and further expands ReciBioPharm’s AAV offerin ...

A study into the origins of COVID-19 has suggested that the virus spread through wildlife trade and did not transfer directly ...

Get insights into Vir Biotechnology's Q1 2025 earnings call, including ECLIPSE Phase III trial progress, oncology updates, and financial highlights.

Influenza viruses are among the most likely triggers of future pandemics. A research team has developed a method that can be used to study the interaction of viruses with host cells in unprecedented ...

A new study published in the journal PLOS Computational Biology reveals how foot traffic data from mobile devices can enhance ...

Learn more about whether Moderna, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The initial spread of the virus that causes COVID-19 might have been accelerated by the wildlife trade, similar to what happened with the SARS outbreak in 2002, according to a study by UC San Diego ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor ...

Studies show how spike protein changes determine the risk of viral outbreaks, offering important insights for the future ...